Literature DB >> 24198418

Adenovirus death protein (ADP) is required for lytic infection of human lymphocytes.

V K Murali1, D A Ornelles, L R Gooding, H T Wilms, W Huang, A E Tollefson, W S M Wold, C Garnett-Benson.   

Abstract

The adenovirus death protein (ADP) is expressed at late times during a lytic infection of species C adenoviruses. ADP promotes the release of progeny virus by accelerating the lysis and death of the host cell. Since some human lymphocytes survive while maintaining a persistent infection with species C adenovirus, we compared ADP expression in these cells with ADP expression in lymphocytes that proceed with a lytic infection. Levels of ADP were low in KE37 and BJAB cells, which support a persistent infection. In contrast, levels of ADP mRNA and protein were higher in Jurkat cells, which proceed with a lytic infection. Epithelial cells infected with an ADP-overexpressing virus died more quickly than epithelial cells infected with an ADP-deleted virus. However, KE37, and BJAB cells remained viable after infection with the ADP-overexpressing virus. Although the levels of ADP mRNA increased in KE37 and BJAB cells infected with the ADP-overexpressing virus, the fraction of cells with detectable ADP was unchanged, suggesting that the control of ADP expression differs between epithelial and lymphocytic cells. When infected with an ADP-deleted adenovirus, Jurkat cells survived and maintained viral DNA for greater than 1 month. These findings are consistent with the notion that the level of ADP expression determines whether lymphocytic cells proceed with a lytic or a persistent adenovirus infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24198418      PMCID: PMC3911668          DOI: 10.1128/JVI.01675-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.

Authors:  Robert Thimme; Marco Binder; Ralf Bartenschlager
Journal:  FEMS Microbiol Rev       Date:  2012-01-04       Impact factor: 16.408

3.  Modeling adenovirus latency in human lymphocyte cell lines.

Authors:  Yange Zhang; Wen Huang; David A Ornelles; Linda R Gooding
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

4.  p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.

Authors:  F D Goodrum; D A Ornelles
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness.

Authors:  J P Fox; C D Brandt; F E Wassermann; C E Hall; I Spigland; A Kogon; L R Elveback
Journal:  Am J Epidemiol       Date:  1969-01       Impact factor: 4.897

6.  Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus.

Authors:  Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; Peter Krajcsi; Ann E Tollefson; William S M Wold
Journal:  Virology       Date:  2003-01-20       Impact factor: 3.616

7.  Interaction of human adenovirus serotype 2 with human lymphoid cells.

Authors:  L Silver; C W Anderson
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

8.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

9.  Productive infection of cultured human lymphoid cells by adenovirus.

Authors:  D Lavery; S M Fu; T Lufkin; S Chen-Kiang
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2.

Authors:  Jude Juventus Aweya; Tze Minn Mak; Seng Gee Lim; Yee-Joo Tan
Journal:  Virus Res       Date:  2012-12-12       Impact factor: 3.303

View more
  9 in total

Review 1.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

2.  Porcine Adenovirus Type 3 E3 Encodes a Structural Protein Essential for Capsid Stability and Production of Infectious Progeny Virions.

Authors:  Abdelrahman Said; Tekeleselassie A Woldemariam; Suresh K Tikoo
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

3.  Simultaneous Single-Cell In Situ Analysis of Human Adenovirus Type 5 DNA and mRNA Expression Patterns in Lytic and Persistent Infection.

Authors:  Tomasz Krzywkowski; Sibel Ciftci; Farzaneh Assadian; Mats Nilsson; Tanel Punga
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  RIPK3 promotes adenovirus type 5 activity.

Authors:  Melanie Weigert; Alex Binks; Suzanne Dowson; Elaine Y L Leung; Dimitris Athineos; Xinzi Yu; Margaret Mullin; Josephine B Walton; Clare Orange; Darren Ennis; Karen Blyth; Stephen W G Tait; Iain A McNeish
Journal:  Cell Death Dis       Date:  2017-12-13       Impact factor: 8.469

Review 5.  Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy.

Authors:  Brennetta J Crenshaw; Leandra B Jones; Courtnee' R Bell; Sanjay Kumar; Qiana L Matthews
Journal:  Biomedicines       Date:  2019-08-19

6.  The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.

Authors:  Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Heat Shock Protein 90 Chaperones E1A Early Protein of Adenovirus 5 and Is Essential for Replication of the Virus.

Authors:  Iga Dalidowska; Olga Gazi; Dorota Sulejczak; Maciej Przybylski; Pawel Bieganowski
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

8.  Human Adenovirus Type 5 Infection Leads to Nuclear Envelope Destabilization and Membrane Permeability Independently of Adenovirus Death Protein.

Authors:  Søren Pfitzner; Jens B Bosse; Helga Hofmann-Sieber; Felix Flomm; Rudolph Reimer; Thomas Dobner; Kay Grünewald; Linda E Franken
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

9.  NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes.

Authors:  Megan L Dickherber; Charlie Garnett-Benson
Journal:  Virol J       Date:  2019-12-21       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.